High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anticancer Research

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.21873/ANTICANRES.11094PMID 27798884
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

  2015cited by this paper
• Targeting of DNA Damage Signaling Pathway Induced Senescence and Reduced Migration of Cancer cells.

  2015cited by this paper
• Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer

  2014cited by this paper
• Aurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks.

  2014cited by this paper
• MRE11-Deficiency Associated with Improved Long-Term Disease Free Survival and Overall Survival in a Subset of Stage III Colon Cancer Patients in Randomized CALGB 89803 Trial

  2014cited by this paper
• The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG‐negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression

  2014cited by this paper
• DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to Chemotherapy

  2014cited by this paper
• Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy

  2013cited by this paper
• Resveratrol induces downregulation of DNA repair genes in MCF-7 human breast cancer cells

  2013cited by this paper
• Increased expression of phosphorylated NBS1, a key molecule of the DNA damage response machinery, is an adverse prognostic factor in patients with de novo myelodysplastic syndromes.

  2013cited by this paper
• Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.

  2013cited by this paper
• FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance

  2013cited by this paper
• Mre 11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA 2 and PARP 1

  2012cited by this paper
• Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer

  2012cited by this paper
• Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

  2012cited by this paper
• Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1.

  2012cited by this paper
• Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance

  2012cited by this paper
• Rad50 Zinc Hook Is Important for the Mre11 Complex to Bind Chromosomal DNA Double-stranded Breaks and Initiate Various DNA Damage Responses*

  2012cited by this paper
• Prognostic Significance of NBS1 and Snail Expression in Esophageal Squamous Cell Carcinoma

  2012cited by this paper
• Differential regulation of MRN (Mre11-Rad50-Nbs1) complex subunits and telomerase activity in cancer cells.

  2010cited by this paper
• Identification of increased NBS1 expression as a prognostic marker of squamous cell carcinoma of the oral cavity

  2010cited by this paper
• ATM Activation by Oxidative Stress

  2010cited by this paper
• Mystery of DNA repair: the role of the MRN complex and ATM kinase in DNA damage repair

  2010cited by this paper
• Molecular disruption of RAD 50 sensitizes human tumor cells to cisplatin-based chemotherapy

  2009cited by this paper
• Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.

  2009cited by this paper
• Multiple roles for Mre11 at uncapped telomeres

  2009cited by this paper
• Oxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation

  2008cited by this paper
• The Mre11-Rad50-Nbs1 Complex Acts Both Upstream and Downstream of Ataxia Telangiectasia Mutated and Rad3-related Protein (ATR) to Regulate the S-phase Checkpoint following UV Treatment*

  2007cited by this paper
• Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer.

  2007cited by this paper
• Overexpression of NBS1 induces epithelial–mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer

  2007cited by this paper
• The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control

  2006cited by this paper
• ATM Activation by DNA Double-Strand Breaks Through the Mre11-Rad50-Nbs1 Complex

  2005cited by this paper
• RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.

  2005cited by this paper
• Transfection of human tumour cells with Mre11 siRNA and the increase in radiation sensitivity and the reduction in heat-induced radiosensitization

  2004cited by this paper
• Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat‐shock

  2004cited by this paper
• c-Myc Directly Regulates the Transcription of the NBS1 Gene Involved in DNA Double-strand Break Repair *

  2003cited by this paper
• Expression of MRE11 Complex (MRE11, RAD50, NBS1) and hRap1 and Its Relation with Telomere Regulation, Telomerase Activity in Human Gastric Carcinomas

  2002cited by this paper
• Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex

  2002cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper

• Role of MRE11 in DNA damage repair pathway dynamics and its diagnostic and prognostic significance in hereditary breast and ovarian cancer

  2025cites this paper
• The role of pathogenic germline mutations of BRCA1/2, NBS1, and CHEK2 genes in gastric cancer development within the Volga-Ural region of Russia

  2025cites this paper
• A review on ribosomal protein S3 (RPS3): Roles in cancer and its resistance to drugs.

  2025cites this paper
• DNA repair and the contribution to chemotherapy resistance

  2025cites this paper
• Drug resistance in ovarian cancer: from mechanism to clinical trial

  2024cites this paper
• Predictive modeling of gene mutations for the survival outcomes of epithelial ovarian cancer patients

  2024cites this paper
• Effects of RAD50 SNP, sodium intake, and H. pylori infection on gastric cancer survival in Korea

  2023cites this paper
• Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR.

  2023cites this paper
• Molecular Biomarkers for Predicting Cancer Patient Radiosensitivity and Radiotoxicity in Clinical Practice

  2023cites this paper
• Identification of Effect of Gene Mutations Related to Telomere Maintenance in Gastric Cancer Patients

  2023cites this paper
• MRE11:p.K464R mutation mediates olaparib resistance by enhancing DNA damage repair in HGSOC

  2023cites this paper
• Silencing TRIM29 Sensitizes Non-small Cell Lung Cancer Cells to Anlotinib by Promoting Apoptosis via Binding RAD50.

  2023cites this paper
• Homologous recombination mRNAs (RAD21, RAD50 and BARD1) have a potentially poor prognostic role in ERBB2-low bladder cancer patients

  2023cites this paper
• The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond

  2023cites this paper
• Breast cancer: miRNAs monitoring chemoresistance and systemic therapy

  2023cites this paper
• Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice

  2022cites this paper
• The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response.

  2022cites this paper
• Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway

  2022cites this paper
• MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients

  2022cites this paper
• Requirements for MRN endonuclease processing of topoisomerase II-mediated DNA damage in mammalian cells

  2022cites this paper
• Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma

  2022cites this paper
• Integrative Expression, Survival Analysis and Cellular miR-2909 Molecular Interplay in MRN Complex Check Point Sensor Genes (MRN-CSG) Involved in Breast Cancer.

  2022cites this paper
• cGAS regulates the DNA damage response to maintain proliferative signaling in gastric cancer cells

  2022cites this paper
• A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma

  2022cites this paper
• Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers

  2022cites this paper
• Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment

  2021cites this paper
• Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers

  2021cites this paper
• Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma

  2021cites this paper
• PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer

  2021cites this paper
• Homologous recombination deficiency: cancer predispositions and treatment implications.

  2021cites this paper
• Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer

  2021cites this paper
• Involvement of ATMIN-DYNLL1-MRN axis in the progression and aggressiveness of serous ovarian cancer.

  2021cites this paper
• Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them

  2021cites this paper
• A highly annotated database of genes associated with platinum resistance in cancer

  2021cites this paper
• Rad50 promotes ovarian cancer progression through NF‐κB activation

  2021cites this paper
• Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer

  2021cites this paper
• GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAFV600E Colorectal Cancer

  2020cites this paper
• MYC Targeted Rad50 Drives Progression of High-Grade Serous Ovarian Cancer via NF-κB Activation

  2020cites this paper
• RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers

  2020cites this paper
• Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem‐like cells contributes to chemoresistance

  2020cites this paper
• Comprehensive profiling of JMJD3 in gastric cancer and its influence on patient survival

  2019cites this paper
• PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma

  2019cites this paper
• MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment

  2019influential citation
• [Bioinformatics analysis of expression and function of EXD3 gene in gastric cancer].

  2019cites this paper
• MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer

  2019cites this paper
• Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment

  2019cites this paper
• Elevated MRE11 expression associated with progression and poor outcome in prostate cancer

  2019cites this paper
• High expression of MRE11 correlates with poor prognosis in gastric carcinoma

  2019cites this paper
• Expression of DNA Damage Response Markers in Early-Onset or Familial Gastric Cancers

  2019influential citation
• Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

  2019cites this paper
• Chemoresistance mechanisms of breast cancer and their countermeasures.

  2019cites this paper
• Microproteomic Profiling of High‐Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic Markers

  2018cites this paper
• Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis

  2018cites this paper
• The molecular mechanisms of chemoresistance in cancers

  2017cites this paper
• Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine.

  2017cites this paper
• Inhibitory effects of recombinant human endostatin combined with cisplatin on transplanted human gastric carcinoma in nude mice

  2017cites this paper
• Co-targeting c-Met and DNA double-strand breaks (DSBs): Therapeutic strategies in BRCA-mutated gastric carcinomas.

  2017cites this paper
• High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma

  2017cites this paper
• The Impact of Post-Translational Regulation of Histone on Cancer Metastasis and Cancer Chemoresistance

  2017cites this paper
• Writing, erasing and reading histone lysine methylations

  2017cites this paper